PRESS RELEASE published on 04/06/2026 at 15:20, 2 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.09% stake in JTC plc. Details of ownership and dealings per regulatory requirement Relevant Securities Financial Dealings The Vanguard Group Ownership Disclosure JTC Plc
BRIEF published on 04/02/2026 at 15:37, 2 months 23 days ago Vanguard Group Discloses Significant Position in Spire Healthcare Form 8.3 Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
BRIEF published on 04/02/2026 at 15:37, 2 months 23 days ago Vanguard Group révèle une participation importante dans Spire Healthcare Spire Healthcare Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières
BRIEF published on 04/02/2026 at 15:35, 2 months 23 days ago The Vanguard Group, Inc. Discloses Position in Schroders plc Form 8.3 Takeover Code Securities Disclosure Vanguard Schroders
BRIEF published on 04/02/2026 at 15:35, 2 months 23 days ago Le groupe Vanguard révèle sa participation dans Schroders plc Code De Prise De Contrôle Formulaire 8.3 Avant-garde Schroders Informations Sur Les Valeurs Mobilières
BRIEF published on 04/02/2026 at 15:34, 2 months 23 days ago The Vanguard Group Discloses Position in Picton Property Income Securities Disclosure The Vanguard Group Takeover Code Picton Property Income
BRIEF published on 04/02/2026 at 15:34, 2 months 23 days ago Le groupe Vanguard révèle sa position dans Picton Property Income Titres Code De Prise De Contrôle Divulgation Le Groupe Vanguard Revenus Fonciers De Picton
BRIEF published on 04/02/2026 at 15:33, 2 months 23 days ago The Vanguard Group Discloses Position in NCC Group Form 8.3 Securities Disclosure Vanguard Group Shareholding NCC Group
BRIEF published on 04/02/2026 at 15:33, 2 months 23 days ago Le groupe Vanguard révèle sa participation dans le groupe NCC. Actionnariat Groupe Vanguard Formulaire 8.3 Information Sur Les Valeurs Mobilières Groupe NCC
PRESS RELEASE published on 04/02/2026 at 15:32, 2 months 23 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses holding 3.61% interest in Spire Healthcare Group plc as of 01 April 2026. Transactions include purchase and sale of 1p ordinary shares Transactions The Vanguard Group, Inc. Disclosure 1p Ordinary Shares Spire Healthcare Group Plc
Published on 06/26/2026 at 01:40, 5 hours 37 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 7 hours 47 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 8 hours 47 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 9 hours 45 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 15 hours 47 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 04:20, 2 hours 57 minutes ago VARON Helps Travelers Breathe Easy This Summer With Portable Oxygen Concentrators Built for Mobility
Published on 06/26/2026 at 02:05, 5 hours 12 minutes ago VARON Marks "Love Your Lungs Week" With a Call to Prioritize Summer Respiratory Health Across Europe
Published on 06/25/2026 at 22:40, 8 hours 37 minutes ago DeFi Technologies Inc. Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Published on 06/25/2026 at 19:00, 12 hours 17 minutes ago EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/25/2026 at 18:59, 12 hours 18 minutes ago OHB Digital Connect completes upgrade of military ground stations
Published on 06/26/2026 at 07:00, 17 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 17 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 12 hours 32 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 12 hours 47 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 13 hours 27 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
